The current valuation score of Abeona Therapeutics Inc is 7.23, ranking 116 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 5.00, which is 36.76% below the recent high of 6.84 and 378.89% above the recent low of -13.94.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.